Innovation Leading Sharing Opportunities ｜ The Third Zhengzhou International Biopharmaceutical Development Summit Forum is held in the airport area

Henan Daily client reporter Yang Ling correspondent Liu Jinglong Jiepan Dan

On August 25th, one of the special activities of the 5th China · Henan Recruitment Capital Exitance Innovation Development Conference "2022 Airport Experimental Zone Recruitment Talent Special Action" The comprehensive experimental area Zhengzhou Linkong Biopharmaceutical Park was held.

Academician of the Chinese Academy of Engineering, Li Xuexuan, Zhang Lihe, academician of the Chinese Academy of Sciences, He Guowei, academician of the French Academy of Medical Sciences, Rodping, Academician of the National Academy of Sciences and Malaysian Academy of Sciences, and Sun Yongkui, academician of the National Academy of Engineering, attended the forum and delivered a speech.

The forum is based on the theme of "Grasp the opportunity of biotechnology drug development", focusing on the transformation of biomedical science and technology achievements, T cell exhaustion and tumor immunotherapy, and the future logic of innovative drug development. Innovate the future. The forum also held the ceremony and project signing ceremony of the development expert members of the Biomedical Industry Development of Zhengzhou Airport Economic Comprehensive Experimental Zone at the same time. This is an opportunity to attract global innovative biopharmaceutical resources to gather Zhengzhou and contribute wisdom and strength to the development of biopharmaceutical research and development and the development of the biopharmaceutical industry. Essence

It is understood that in recent years, the Zhengzhou Airport Experimental Zone has grasped the general trend of the industry and promoted the development of the industry. By actively cultivating the advantageous industrial clusters, it has accelerated the rapid development of biomedicine, aviation logistics, and high -end manufacturing industry clusters. Among them The high value -added and dependence on professional logistics and efficient customs clearance has become one of the core industries of the aviation port experimental area.

As an important carrier of the national high -tech biological industry base of the Airport Experimental Zone, Zhengzhou Liming Biological Pharmaceutical Park is like a shining star, which has grown to support a new high -quality development of the regional economy. Data show that as of May 2022, there were 41 enterprises in the park and 34 in the park. The leading enterprises in the medical fields such as Hua Ning, Zhengzhou Shengsi, and Taiji Hongnuo landed in the park. Internationally -leading innovative drugs in hemophilia, diabetes, etc. have entered clinical research, and it is expected to be listed worldwide in the next 3 to 5 years. Among them, the long -term reorganized protein drug FRSW107 project for the treatment of hemophilia has submitted a listing permit for listing and accepted to the National Drug Administration.

As a knowledge -intensive industry, the development of the biomedical industry is inseparable from the support of continuous, high -quality, and all -round talent. After 6 years of development, Zhengzhou Linkong Biomedical Park introduced more than 1,200 professional talents, including 48 doctors, gathered a number of scientists, entrepreneurs and innovative entrepreneurs in the field of biomedical. It is estimated that by 2025, the output value of Zhengzhou Airport Biomedical Industrial Zone will exceed 30 billion yuan, which will be expected to exceed 10,000 professionals. The biomedical industry has achieved high -quality development.

At the forum, a number of academicians scientists, famous clinical R & D experts, chairman of pharmaceutical listed enterprises and founders of venture capital institutions shared themes Carry out forward -looking, authoritative, and foresight communication dialogue with themes such as high -end manufacturing, and comprehensively demonstrate the cutting -edge progress of the sub -sectors of the biomedical industry.

It is reported that the Zhengzhou Airport Experimental Zone has successfully held three sessions of Zhengzhou International Biopharmaceutical Development Summit Forum, becoming the highest and most influential professional summit in Henan Province. The industrial business card of the "Biopharmaceutical Capital" pushed the industry's forefront to the industry.

- END -